在上调评级后，Jefferies强调了该股在最近回调后的吸引人估值，指出其现在仅以17-18倍2025年预期收益进行交易。这一估值低于同行平均水平，并且较近期高点约20倍收益率有显著下降。

Shares of GE HealthCare Technologies Inc. GEHC rose 2.02% to $83.37 Tuesday, on what proved to be an all-around dismal ...

近日，GE医疗的工程副总裁、女性健康和X射线业务首席技术官兼印度技术中心工程副总裁Girish ...

President-elect Donald Trump’s proposed tariffs on good from Canada, Mexico and China could raise costs, disrupt supply ...

2025年1月3日，医疗保健设备公司GE HealthCare（GEHC）成交额为2.17亿美元，在当日美股中排第323名，成交额较昨日增加4.56%，当日成交量为271.26万。 GE HealthCare（GEHC）于2025年1月3日涨2.73%，报80.52美元，该股过去5个交易日涨1.27%，整个1月涨2.99%，年初至今涨2.99%，过去52周涨5.16%。 *如果公司上市时间少于52 ...

Evercore ISI lowered the firm’s price target on GE HealthCare (GEHC) to $98 from $102 and keeps an Outperform rating on the shares. In the ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totalling 9,240 ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Girish Raghavan, the CTO of Women’s Health and X-Ray and VP of Engineering, GE HealthCare Technology Centre India, talks ...

Despite a setback when one of its wind turbines broke on its Vineyard Wind project, General Electric’s energy businesses are ...

Claypond Capital appoints Dr. Shravan Subramanyam to lead medical technology platform for domestic and export markets.